RCSB PDB: Search

5AP0 \| pdb_00005ap0	Download File View File

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

Gurden, M.D., Westwood, I.M., Faisal, A., Naud, S., Cheung, K.J., McAndrew, C., Wood, A., Schmitt, J., Boxall, K., Mak, G., Workman, P., Burke, R., Hoelder, S., Blagg, J., van Montfort, R.L.M., Linardopoulos, S.

(2015) Cancer Res 75: 3340

Released	2015-09-23
Method	X-RAY DIFFRACTION 2.15 Å
Organisms	Homo sapiens
Macromolecule	DUAL SPECIFICITY PROTEIN KINASE TTK (protein)
Unique Ligands	AU5, DMS, EDO, P4C

Explore in 3D

5AP1 \| pdb_00005ap1	Download File View File

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

Gurden, M.D., Westwood, I.M., Faisal, A., Naud, S., Cheung, K.J., McAndrew, C., Wood, A., Schmitt, J., Boxall, K., Mak, G., Workman, P., Burke, R., Hoelder, S., Blagg, J., van Montfort, R.L.M., Linardopoulos, S.

(2015) Cancer Res 75: 3340

Released	2015-09-23
Method	X-RAY DIFFRACTION 2.05 Å
Organisms	Homo sapiens
Macromolecule	DUAL SPECIFICITY PROTEIN KINASE TTK (protein)
Unique Ligands	GOL, MG, O38

Explore in 3D

5AP2 \| pdb_00005ap2	Download File View File

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

Gurden, M.D., Westwood, I.M., Faisal, A., Naud, S., Cheung, K.J., McAndrew, C., Wood, A., Schmitt, J., Boxall, K., Mak, G., Workman, P., Burke, R., Hoelder, S., Blagg, J., van Montfort, R.L.M., Linardopoulos, S.

(2015) Cancer Res 75: 3340

Released	2015-09-23
Method	X-RAY DIFFRACTION 2.8 Å
Organisms	Homo sapiens
Macromolecule	DUAL SPECIFICITY PROTEIN KINASE TTK (protein)
Unique Ligands	PWU

Explore in 3D

5AP3 \| pdb_00005ap3	Download File View File

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

Gurden, M.D., Westwood, I.M., Faisal, A., Naud, S., Cheung, K.J., McAndrew, C., Wood, A., Schmitt, J., Boxall, K., Mak, G., Workman, P., Burke, R., Hoelder, S., Blagg, J., van Montfort, R.L.M., Linardopoulos, S.

(2015) Cancer Res 75: 3340

Released	2015-09-23
Method	X-RAY DIFFRACTION 2.7 Å
Organisms	Homo sapiens
Macromolecule	DUAL SPECIFICITY PROTEIN KINASE TTK (protein)
Unique Ligands	7PE, AU5, DMS, EDO

Explore in 3D

5AP4 \| pdb_00005ap4	Download File View File

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

Gurden, M.D., Westwood, I.M., Faisal, A., Naud, S., Cheung, K.J., McAndrew, C., Wood, A., Schmitt, J., Boxall, K., Mak, G., Workman, P., Burke, R., Hoelder, S., Blagg, J., van Montfort, R.L.M., Linardopoulos, S.

(2015) Cancer Res 75: 3340

Released	2015-09-23
Method	X-RAY DIFFRACTION 2.85 Å
Organisms	Homo sapiens
Macromolecule	DUAL SPECIFICITY PROTEIN KINASE TTK (protein)
Unique Ligands	7PE, EDO, O38

Explore in 3D

5AP5 \| pdb_00005ap5	Download File View File

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

Gurden, M.D., Westwood, I.M., Faisal, A., Naud, S., Cheung, K.J., McAndrew, C., Wood, A., Schmitt, J., Boxall, K., Mak, G., Workman, P., Burke, R., Hoelder, S., Blagg, J., van Montfort, R.L.M., Linardopoulos, S.

(2015) Cancer Res 75: 3340

Released	2015-09-23
Method	X-RAY DIFFRACTION 2.8 Å
Organisms	Homo sapiens
Macromolecule	DUAL SPECIFICITY PROTEIN KINASE TTK (protein)
Unique Ligands	1KA, 7RO, EDO, PGE

Explore in 3D

5F4N \| pdb_00005f4n	Download File View File

Multi-parameter lead optimization to give an oral CHK1 inhibitor clinical candidate: (R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)

Collins, I., Garrett, M.D., van Montfort, R., Osborne, J.D., Matthews, T.P., McHardy, T., Proisy, N., Cheung, K.J., Lainchbury, M., Brown, N., Walton, M.I., Eve, P.D., Boxall, K.J., Hayes, A., Henley, A.T., Valenti, M.R., De Haven Brandon, A.K., Box, G., Westwood, I.M., Jamin, Y., Robinson, S.P., Leonard, P., Reader, J.C., Aherne, G.W., Raynaud, F.I., Eccles, S.A.

(2016) J Med Chem 59: 5221-5237

Released	2016-05-25
Method	X-RAY DIFFRACTION 1.91 Å
Organisms	Homo sapiens
Macromolecule	Serine/threonine-protein kinase Chk1 (protein)
Unique Ligands	5UY, EDO, GOL

5AP0 | pdb_00005ap0

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP1 | pdb_00005ap1

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP2 | pdb_00005ap2

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP3 | pdb_00005ap3

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP4 | pdb_00005ap4

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP5 | pdb_00005ap5

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5F4N | pdb_00005f4n

Multi-parameter lead optimization to give an oral CHK1 inhibitor clinical candidate: (R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)

Prepare Data

Validate Data

Deposit Data

Help and Resources

Structure Determination Methodology

Scientific Name of Source Organism

Taxonomy

Experimental Method

Polymer Entity Type

Refinement Resolution (Å)

Release Date

Enzyme Classification Name

Symmetry Type

SCOP Classification

5AP0 | pdb_00005ap0

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP1 | pdb_00005ap1

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP2 | pdb_00005ap2

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP3 | pdb_00005ap3

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP4 | pdb_00005ap4

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5AP5 | pdb_00005ap5

Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.

5F4N | pdb_00005f4n

Multi-parameter lead optimization to give an oral CHK1 inhibitor clinical candidate: (R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)